News & Publications

News & Press Releases » Events

MPP at ICASA 2021

Durban, South Africa

26 November 2021

News & Press Releases » Press Releases

WHO and MPP announce the first transparent, global, non-exclusive licence for a COVID-19 technology

23 November 2021

News & Press Releases » Press Releases

Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries

16 November 2021

Messages from the Executive Director

World Hepatitis Day 2021: Hepatitis Can’t Wait! – Message from Charles Gore, MPP’s Executive Director

28 July 2021

Messages from the Executive Director

Message from the Executive Director Charles Gore on World Health Day 2021

07 April 2021

Messages from the Executive Director

10 Years of MPP – Message from Charles Gore, MPP’s Executive Director

11 December 2020

MPP in the Media

The Medicines Patent Pool Plots A Post-Pandemic Future: Interview With Director Charles Gore

23 September 2021

MPP in the Media

MPP featured in the World Economic Forum ahead of the Davos Agenda 2021

26 January 2021

MPP in the Media

COVID-19 puts a spotlight on the Medicines Patent Pool – Devex

22 June 2020

Related Publications

Transitioning to the 2021 optimal formulary for antiretroviral drugs for children: implementation considerations – WHO policy brief

19 July 2021

Related Publications

The 2021 optimal formulary and limited-use list for antiretroviral drugs for children – WHO policy brief

30 April 2021

Related Publications

MPP is proud to be among the high scorers of the Global Health 50/50 2021 Report, Gender equality: Flying blind in a time of crisis

08 March 2021